The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said in March.
That being said, the most common side effects are nausea, vomiting, constipation, and diarrhea
Risultati e studi clinici Studi recenti (SURMOUNT-5, NEJM 2025) hanno evidenziato che la tirzepatide, alla dose di 15 mg/settimana, in grado di indurre una riduzione media del peso corporeo del 26,6% in 88 settimane, significativamente superiore a quella ottenuta con semaglutide 2.4 mg (18,2%)
Related reading on GLP-1 medications and hair loss: Mounjaro and Tirzepatide Hair Loss: Why It Happens and What You Can Do Wegovy and Hair Loss: Why It Happens and What You Can Do
Frequently asked questions Is sermorelin better than semaglutide for weight loss